Etelcalcetide: What we know eight years since its approval Pedro Freitas; Luciano Pereira;

Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology Fabiola Alonso; Ángel L.M. Martín de Francisco; Pilar Auñón; Clara García-Carro; Patricia García; Eduardo Gutiérrez; Manuel Mcía; Luis F. Quintana; Borja Quiroga; María José Soler; Isidro Torregrosa;

Kidney transplant in the next decade: Strategies, challenges and vision of the future Domingo Hernández; Abelardo Caballero;